Yao-Chung Liu
Overview
Explore the profile of Yao-Chung Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Lin T, Fan N, Ko P, Wang H, Tsai C, et al.
J Microbiol Immunol Infect
. 2024 Dec;
PMID: 39627110
Background: In recent years, haploidentical hematopoietic stem cell transplantation (haploHSCT) with post-transplant cyclophosphamide (PTCy) has become increasingly prevalent. However, the precise impact of invasive fungal disease (IFD) in relation to...
2.
Hsu T, Tsai C, Liu C, Yeh C, Lin F, Hsiao L, et al.
Ann Hematol
. 2024 Mar;
103(8):2893-2904.
PMID: 38472362
Multiple myeloma (MM) stands as the second most prevalent hematological malignancy, constituting approximately 10% of all hematological malignancies. Current guidelines recommend upfront autologous stem cell transplantation (ASCT) for transplant-eligible MM...
3.
Chien S, Huang H, Chen Y, Tsai Y, Lu S, Lee L, et al.
Ann Hematol
. 2024 Feb;
103(4):1389-1396.
PMID: 38393657
Transfusion reactions induced by platelet transfusions may be reduced and alleviated by leukocyte reduction of platelets. Although leukoreduction of apheresis platelets can be performed either pre-storage or post-storage, seldom studies...
4.
Wang H, Yang F, Yang C, Liu Y, Ko P, Li C, et al.
Exp Hematol Oncol
. 2023 Apr;
12(1):35.
PMID: 37029450
Introduction: Circulating monocytic myeloid-derived suppressive cells (M-MDSCs) are implicated as a poor prognostic factor and cause CAR T-cell failure in diffuse large B-cell lymphoma (DLBCL). Triggering receptors expressed on myeloid...
5.
Hsu T, Tsai C, Liu C, Yeh C, Lin F, Hsiao L, et al.
Transfus Med Hemother
. 2023 Feb;
50(1):39-50.
PMID: 36818774
Introduction: Autologous hematopoietic stem cell transplantation (ASCT) is a well-established treatment for patients with multiple myeloma (MM), and adequate stem cell collection must be assured before ASCT. However, prediction of...
6.
Wang H, Yang C, Lin C, Hsiao L, Ko P, Liu Y, et al.
Cancer Med
. 2023 Jan;
12(7):8089-8101.
PMID: 36647765
Background: Frontline intensification (including consolidative whole-brain radiotherapy or high-dose chemotherapy with autologous stem-cell transplantation after induction therapy) has been proposed to treat primary central nervous system lymphoma (PCNSL). However, no...
7.
Jiang J, Liu C, Yeh C, Yang C, Liu Y, Wang H, et al.
Hematol Oncol
. 2022 Oct;
41(1):167-177.
PMID: 36305496
Hemophagocytic lymphohistiocytosis (HLH) is a heterogeneous group of hyperinflammatory statuses that are difficult to diagnose and can be life-threatening. Bone marrow (BM) hemophagocytosis is one of the diagnostic criteria according...
8.
Lin W, Tsai C, Yeh C, Chian T, Liu Y, Wang H, et al.
Cancer Med
. 2022 Sep;
12(3):3013-3026.
PMID: 36127838
Background: Multiple myeloma (MM) is known for its immune disturbance and patients suffering from MM are thus vulnerable to opportunistic infections, including herpes zoster (HZ). As HZ infection remarkably affects...
9.
Liu Y, Kwon J, Fabiani E, Xiao Z, Liu Y, Follo M, et al.
N Engl J Med
. 2022 May;
386(21):1998-2010.
PMID: 35613022
Background: Although hypomethylating agents are currently used to treat patients with cancer, whether they can also reactivate and up-regulate oncogenes is not well elucidated. Methods: We examined the effect of...
10.
Yang J, Gao C, Liu M, Liu Y, Kwon J, Qi J, et al.
Cancer Res
. 2021 Oct;
81(23):6018-6028.
PMID: 34593523
Oncofetal protein SALL4 is critical for cancer cell survival. Targeting SALL4, however, is only applicable in a fraction of cancer patients who are positive for this gene. To overcome this...